We establish that aged Cyfip2 heterozygotes develop amyloid and tau pathology, gliosis, spine loss and more severe memory impairment than in young age, indicating that reduction of a single endogenous mouse gene can cause key aspects of AD-type pathology in the mouse brain. Here, MAPT is linked to Alzheimer disease.